Anavex Life Sciences Corp (AVXL)

[falconer66a]

And is still the case.

Friday's selling began before the presentation and PR and continued before anyone could have evaluated their contents. The reported data was not driving the stock price.

I, too, had the AVXL share price on my screen Friday. Yep, "profit-taking," share price reductions, started way before 10:45am, before any Anavex data were posted or known to conference attendees.

Anyone, then, wanna explain how the sellers knew before the scheduled presentation that the data would be "negative?"

Don't try. They did know such a thing. In fact, the clinical data posted at the event are very positive. Blarcamesine is both safe (no obviating or concerning side effects) and effective (dementia patients taking the drug had better cognition, thinking, than placebo patients).

Anavex naysayers have had to search minutely for any negative data. None were presented; so, it is proposed some negative data were withheld by the company. Sure.

Will anything change when the peer-reviewed journal article, telling the details of the clinical trial, appears? Let's see. But even if it's entirely positive (as it will be), it won't be an FDA approval to sell the drug. But it will provide the details to move toward that eventual goal.